Analystreport

Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $8.00 price target on the stock, down previousl...

Galmed Pharmaceuticals Ltd. - Ordinary Shares  (GLMD) 
Last galmed pharmaceuticals ltd. - ordinary shares earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: galmedpharma.investorroom.com